Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Wirth

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 5, 2010
The German S3 guideline prostate cancer: aspects for the radiation oncologistFrederik Wenz, Thomas Martin, Dirk Böhmer, et al.
BJU International|March 4, 2016
Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsyAngelika Borkowetz, Ivan Platzek, Marieta Toma, et al.
Urologia Internationalis|December 22, 2012
Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: results from a phase IIIb study (NCT00831233)John Anderson, Ghandi Al-Ali, Manfred Wirth, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2002
Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic ratsKay-Dietrich Wagner, Vanja Essmann, Karsten Mydlak, et al.
European Urology|June 25, 2013
A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapyManfred Wirth, Axel Heidenreich, Jürgen E Gschwend, et al.
European Urology|October 18, 2011
Current vaccination strategies for prostate cancerSteven Joniau, Per-Anders Abrahamsson, Joaquim Bellmunt, et al.
European Urology|February 27, 2007
Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progressionMichael Lein, Manfred Wirth, Kurt Miller, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
European Urology|August 24, 2010
Medical students' exposure to urology in European schools: the European Association of Urology proposals for a convergence programmeRemigio Vela Navarrete, Alain Le Duc, Rolf Ackermann, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 5, 2010
The German S3 guideline prostate cancer: aspects for the radiation oncologistFrederik Wenz, Thomas Martin, Dirk Böhmer, et al.
BJU International|March 4, 2016
Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsyAngelika Borkowetz, Ivan Platzek, Marieta Toma, et al.
Urologia Internationalis|December 22, 2012
Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: results from a phase IIIb study (NCT00831233)John Anderson, Ghandi Al-Ali, Manfred Wirth, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2002
Decreased susceptibility of cardiac function to hypoxia-reoxygenation in renin-angiotensinogen transgenic ratsKay-Dietrich Wagner, Vanja Essmann, Karsten Mydlak, et al.
European Urology|June 25, 2013
A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapyManfred Wirth, Axel Heidenreich, Jürgen E Gschwend, et al.
European Urology|October 18, 2011
Current vaccination strategies for prostate cancerSteven Joniau, Per-Anders Abrahamsson, Joaquim Bellmunt, et al.
European Urology|February 27, 2007
Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progressionMichael Lein, Manfred Wirth, Kurt Miller, et al.
BMC Cancer|January 8, 2019
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access programAxel Heidenreich, Silke Gillessen, Daniel Heinrich, et al.
Clinical Genitourinary Cancer|July 18, 2019
Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access ProgramFred Saad, Silke Gillessen, Daniel Heinrich, et al.
European Urology|August 24, 2010
Medical students' exposure to urology in European schools: the European Association of Urology proposals for a convergence programmeRemigio Vela Navarrete, Alain Le Duc, Rolf Ackermann, et al.
Pageof 10